webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-Phe-Lys(Trt)-PAB

  CAS No.: 1116085-98-3   Cat No.: BADC-00709   Purity: 95% 4.5  

Fmoc-Phe-Lys(Trt)-PAB is a peptide-based ADC linker intermediate with Fmoc and Trt protections and a para-aminobenzyl (PAB) spacer, designed for enzyme-cleavable payload release in antibody-drug conjugates, improving therapeutic targeting and stability. Keywords: ADC linker, peptide linker, enzyme-cleavable, Fmoc, Trt protection.

Fmoc-Phe-Lys(Trt)-PAB

Structure of 1116085-98-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C56H54N4O5
Molecular Weight
863.00
Shipping
Room temperature, or blue ice upon request.
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(9H-Fluoren-9-yl)methyl ((S)-1-(((S)-1-amino-1-oxo-6-(tritylamino)hexan-2-yl)(4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate
Canonical SMILES
C1=CC=C(C=C1)CC(C(=O)N(C2=CC=C(C=C2)COC(=O)OC3=CC=C(C=C3)[N+](=O)[O-])C(CCCCNC(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C(=O)N)NC(=O)OCC7C8=CC=CC=C8C9=CC=CC=C79
InChI
InChI=1S/C63H57N5O9/c64-59(69)58(31-17-18-40-65-63(46-21-7-2-8-22-46,47-23-9-3-10-24-47)48-25-11-4-12-26-48)67(49-34-32-45(33-35-49)42-76-62(72)77-51-38-36-50(37-39-51)68(73)74)60(70)57(41-44-19-5-1-6-20-44)66-61(71)75-43-56-54-29-15-13-27-52(54)53-28-14-16-30-55(53)56/h1-16,19-30,32-39,56-58,65H,17-18,31,40-43H2,(H2,64,69)(H,66,71)/t57-,58-/m0/s1
InChIKey
LOGURWMJSNXIEZ-YQOHNZFASA-N
Shipping
Room temperature, or blue ice upon request.
Storage
-20°C

Fmoc-Phe-Lys(Trt)-PAB, a versatile peptide building block, plays a pivotal role in solid-phase peptide synthesis (SPPS) for constructing intricate peptide chains. Here are four key applications of Fmoc-Phe-Lys(Trt)-PAB:

Peptide Drug Development: Widely used in synthesizing peptide-based drugs, Fmoc-Phe-Lys(Trt)-PAB is crucial in combating various medical conditions like diabetes, cancer, and infectious diseases. The Fmoc protecting group facilitates selective reactions during SPPS, enabling the precise assembly of therapeutic peptides. This precision is paramount in developing potent and stable peptide drugs with targeted efficacy.

Enzyme Substrate Screening: In the realm of peptide library creation, Fmoc-Phe-Lys(Trt)-PAB aids in screening potential enzyme substrates, allowing researchers to construct diverse peptide sequences for testing against different enzymes. These experiments are instrumental in uncovering specific substrate-enzyme interactions, offering insights into enzyme specificity and kinetics through a multifaceted approach.

Biomaterial Research: Within biomaterial design, Fmoc-Phe-Lys(Trt)-PAB can be integrated into peptide sequences that autonomously assemble into nanostructures or hydrogels, finding applications in tissue engineering, drug delivery, and regenerative medicine. The meticulous control over peptide structure afforded by SPPS techniques enhances the functional attributes of resultant biomaterials, fostering innovation in the field.

Structural Biology: Employed in synthesizing peptides for structural biology investigations, including nuclear magnetic resonance (NMR) and X-ray crystallography studies, Fmoc-Phe-Lys(Trt)-PAB enables accurate peptide synthesis to generate protein fragments or peptide inhibitors for three-dimensional structure elucidation. This knowledge is indispensable for unraveling protein functionality and facilitating drug design through a comprehensive exploration of molecular intricacies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Mal-PEG8-NHS | MC-PEG2-C2-NHS ester | perfluorophenyl 3-(pyridin-2-yldisulfanyl)propanoate | N-succinimidyl-6-(2-pyridyldithio)capronate | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate | MAL-Di-EG-OPFP | N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-L-alanine | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate | Maleimide-NH-PEG10-CH2CH2COONHS Ester | perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate | Fmoc-Phe-Lys(Trt)-PAB
Send Inquiry
Verification code
Inquiry Basket